JTCS Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galinanes, M.
Right arrow Articles by Hearse, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galinanes, M.
Right arrow Articles by Hearse, D. J.

The Journal of Thoracic and Cardiovascular Surgery, Vol 103, 521-531, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Effect of sodium aspartate on the recovery of the rat heart from long- term hypothermic storage

M Galinanes, DJ Chambers and DJ Hearse
Department of Cardiovascular Research, Rayne Institute, St Thomas' Hospital, London, United Kingdom.

We have investigated the reported ability of aspartate to enhance greatly the cardioprotective properties of the St. Thomas' Hospital cardioplegic solution after prolonged hypothermic storage. Rat hearts (n = 8 per group) were excised and subjected to immediate arrest with St. Thomas' Hospital cardioplegic solution (2 minutes at 4 degrees C) with or without addition of monosodium aspartate (20 mmol/L). The hearts were then immersed in the same solution for 8 hours (4 degrees C) before heterotopic transplantation into the abdomen of homozygous rats and reperfusion in vivo for 24 hours. The hearts were then excised and perfused in the Langendorff mode (20 minutes). Addition of aspartate to St. Thomas' Hospital cardioplegic solution gave a small but significant improvement in left ventricular developed pressure, which recovered to 82 +/- 3 mm Hg compared with 70 +/- 2 mm Hg in control hearts (p less than 0.05). However, coronary flow and high- energy phosphate content were similar in both groups. In subsequent experiments hearts (n = 8 per group) were excised, arrested (2 minutes at 4 degrees C) with St. Thomas' Hospital cardioplegic solution containing a 0, 5, 10, 20, 30, 40, or 50 mmol/L concentration of aspartate, stored for 8 hours at 4 degrees C, and then reperfused for 35 minutes. A bell-shaped dose-response curve was obtained, with maximum recovery in the 20 mmol/L aspartate group (cardiac output, 48 +/- 5 ml/min versus 32 +/- 5 ml/min in the aspartate-free control group; p less than 0.05). However, additional experiments showed that a comparable improvement could be achieved simply by increasing the sodium concentration of St. Thomas' Hospital cardioplegic solution by 20 mmol/L. Similarly, if sodium aspartate (20 mmol/L) was added and the sodium content of the St. Thomas' Hospital cardioplegic solution reduced by 20 mmol/L, no significant protection was observed when recovery was compared with that of unmodified St. Thomas' Hospital cardioplegic solution alone. In still further studies, hearts (n = 8 per group) were perfused in the working mode at either high (greater than 80 ml/min) or low (less than 50 ml/min) left atrial filling rates. Under these conditions, if functional recovery was expressed as a percentage of preischemic function, artifactually high recoveries could be obtained in the low-filling-rate group. In conclusion, assessment of the protective properties of organic additives to cardioplegic solutions requires careful consideration of (1) the consequences of coincident changes in ionic composition and (2) the characteristics of the model used for assessment.


This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. R. Ghomeshi, G. Tian, J. Ye, J. Sun, E. F. Hoffenberg, T. A. Salerno, and R. Deslauriers
ASPARTATE/GLUTAMATE-ENRICHED BLOOD DOES NOT IMPROVE MYOCARDIAL ENERGY METABOLISM DURING ISCHEMIA-REPERFUSION: A 31P MAGNETIC RESONANCE SPECTROSCOPIC STUDY IN ISOLATED PIG HEARTS
J. Thorac. Cardiovasc. Surg., June 1, 1997; 113(6): 1068 - 1080.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. S. Sett, H. Tearle, and J. G. LeBlanc
EFFECT OF GLUTAMATE-ASPARTATE REPERFUSION ON POSTISCHEMIC NEONATAL MYOCARDIUM
J. Thorac. Cardiovasc. Surg., March 1, 1997; 113(3): 462 - 466.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
O. I. Pisarenko, F. L. Rosenfeldt, L. Langley, R. A. J. Conyers, and S. M. Richards
Differing Protection With Aspartate and Glutamate Cardioplegia in the Isolated Rat Heart
Ann. Thorac. Surg., June 1, 1995; 59(6): 1541 - 1548.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1992 by The American Association for Thoracic Surgery.